C12Y 302/01087
Capsular-polysaccharide endo-1,3-alpha-galactosidase
Official title: Capsular-polysaccharide endo-1,3-alpha-galactosidase (3.2.1.87)
C12Y302/01087 (Capsular-polysaccharide endo-1,3-alpha-galactosidase) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 4
- Assignees
- 3
- Inventors
- 11
- Latest grant
- 19 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Immunogenic composition12 Sep 2024US 2024/0299474 A1Glaxosmithkline Biologicals SA
- Depolymerase capable of degrading extracellular polymeric substances of klebsiella pneumoniae30 Jun 2022US 2022/0202917 A1Shanghai Ruizhou Biotech Co., Ltd
- Immunogenic composition21 Mar 2019US 2019/0083552 A1Glaxosmithkline Biologicals SA
- Recombinant poly-glutamic acid depolymerases9 Sep 2010US 2010/0226906 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.